Vascular Stents Patent Landscape Report 2026 Edition

The global vascular stents market was valued at USD 11.15 Billion in 2025. The market is anticipated to grow at a CAGR of 5.50% during the forecast period of 2026-2035, with the values likely to reach USD 19.05 Billion by 2035. The market growth is driven by the rising prevalence of cardiovascular diseases (CVDs) across the globe. Patents are focused on advanced technologies such as drug-eluting and covered, among others.

Patent Landscape Report Coverage

The Global Vascular Stents Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for vascular stents include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with vascular stents. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within vascular stent technologies.

Key Inclusions:

• Patent Valuation Analysis

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for vascular stent technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with vascular stents.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for vascular stents and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for vascular stents and their relative value in the IP are covered in the final report.

What are Vascular Stents?

Vascular stents are small, mesh-like tubes used to maintain blood vessel openings and guarantee appropriate blood flow. They are usually placed in arteries that have blockages brought on by atherosclerosis, a disorder in which plaque accumulates in the arteries. Depending on their composition and purpose, stents can be bioresorbable, drug-eluting, or bare metal. They are frequently used to prevent vessel narrowing and lower the risk of heart attacks and strokes in peripheral artery and coronary artery diseases.

The components of vascular stents include coronary and peripheral. Mesh tubes called peripheral vascular stents are used to maintain adequate blood flow in the peripheral vascular system by keeping blocked or constricted arteries open. To treat peripheral artery disease (PAD) brought on by atherosclerosis, they are frequently implanted in the carotid arteries, kidneys, arms, and legs. By enhancing mobility and reducing symptoms like pain, these stents help lower the risk of major side effects like stroke or limb ischemia.

Vascular Stents Industry Growth Drivers

Technological Advancements in Stent Design is Expected to Boost the Patent Industry Growth

Innovations like drug-eluting stents (DES), bioresorbable stents, and next-generation coated stents are leading to a decline in restenosis rates and improvements in patient outcomes. For instance, in September 2021, Boston Scientific received a U.S. patent for a novel drug-eluting stent that has a sophisticated polymer coating that improves drug release for improved arterial healing.

There is an increase in patent activity which focuses on enhancing the performance of vascular stents. In 2023, 2,378 patents were granted which increased to 2,547 by 2024. Patents covering these technologies are crucial for companies and thus impact the vascular stents patent landscape.

Increasing Prevalence of Cardiovascular Diseases (CVDs) is Expected to Propel Vascular Stents Patent Industry

Vascular stent demand is being driven by the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) brought on by the rising aging populations, sedentary lifestyles, and poor diets. The number of stent-based interventions is rising due to the rising global burden of CVDs.

Vascular Stents Patent Segmentation

The report will cover the following sections in detail:

Analysis by Technology

• Drug-Eluting
• Covered

Analysis by Product

• Coronary
• Peripheral
• Carotid
• Renal

Analysis by Mode of Delivery

• Balloon-Expandable
• Self-Expanding

Analysis by Material

• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Chromium
• Stainless Steel
• Polymer
• Others

Vascular Stents Patent Segmentation Analysis

The breakup based on the mode of delivery includes balloon-expandable and self-expanding. Balloon-expandable vascular stents are crimped onto a balloon catheter. These stiff, mesh-like tubes expand when the balloon is inflated. Strong radial support is offered by these stents, which are frequently used in peripheral and coronary artery interventions, especially in regions like the carotid and renal arteries that demand exact placement. They provide good scaffolding but are less flexible than self-expanding stents because they are made of materials like cobalt-chromium or stainless steel.

Vascular Stents Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for vascular stent patents, having around 93,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with vascular stents patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the vascular stents field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Boston Scient Scimed Inc.

The company was founded in 1979 and is based in Maple Grove, Minnesota, in the United States. With cutting-edge technologies like drug-eluting stents, bioresorbable stents, and peripheral vascular stents, it is a major player in the global vascular stents market. In order to enhance patient outcomes in interventional cardiology and endovascular therapies, the company prioritizes innovation and minimally invasive solutions.

Medtronic Vascular Inc.

Medtronic was established in 1949 and has its headquarters in Dublin, Ireland. Its vascular division is based in California, United States. Offering drug-eluting, bare-metal, and peripheral vascular stents, the company is a major player in the market. Medtronic specializes in cutting-edge, minimally invasive treatments to help patients with peripheral artery disease (PAD) and coronary artery disease (CAD) achieve better results.

Other companies include Cook Medical Technologies Llc, Abbott Cardiovascular Systems, and Advanced Cardiovascular System, among others.

Reasons to Purchase this Report

The vascular stents patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of vascular stents.
• Innovation Insights: The patent analysis reveals new innovations and technologies in vascular stents.
• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the vascular stents patent landscape.
• Risk Assessment: In technology-intensive fields such as vascular stents, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Vascular Stents Patent Landscape Report

• Who are the key players in the vascular stents patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in vascular stent patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the vascular stents industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in vascular stents?
• What are the challenges and opportunities in the vascular stents patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in vascular stents?